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Lysosome membrane recycling occurs at the end of
the autophagic pathway and requires proteins that
are mostly encoded by genes mutated in neurode-
generative diseases. However, its implication in
neuronal death is still unclear. Here, we show that
spatacsin, which is required for lysosome recycling
andwhose loss of function leads to hereditary spastic
paraplegia 11 (SPG11), promotes clearance of gangli-
osides from lysosomes in mouse and human SPG11
models. We demonstrate that spatacsin acts down-
stream of clathrin and recruits dynamin to allow lyso-
some membrane recycling and clearance of ganglio-
sides from lysosomes. Gangliosides contributed to
the accumulation of autophagymarkers in lysosomes
and to neuronal death. In contrast, decreasing gangli-
oside synthesis prevented neurodegeneration and
improved motor phenotype in a SPG11 zebrafish
model. Our work reveals how inhibition of lysosome
membrane recycling leads to the deleterious accumu-
lation of gangliosides, linking lysosome recycling to
neurodegeneration.
INTRODUCTION
Lysosomesare essential organellesnecessary for thedegradation
of cellular components by the action of hydrolytic enzymes. TheyCell
This is an open access article under the CC BY-Nare involved in endocytosis and autophagy pathways to promote
the degradation of the content of late endosomes and autophago-
somes. The degradation step is followed by recycling of structural
components into newly forming lysosomes. Under normal condi-
tions, recycling of lysosomal membranes has been proposed to
result from the budding of small vesicle carriers from lysosomes
(Sridhar et al., 2013). However, under starvation conditions, tubu-
lation occurs in autolysosomes to promote the reformation of new
functional lysosomes, a process called autophagic lysosome
reformation (ALR) (Yu et al., 2010). The proteins involved in the re-
cyclingprocess includekinesinKIF5B (Duetal., 2016), clathrin, the
lipid-modifying enzymes PIP5K1B and PIP5K1A (Rong et al.,
2012), spatacsin and spastizin (Chang et al., 2014), members of
the AP-2 and AP-4 complex (Rong et al., 2012), dynamin (Schulze
et al., 2013), andSPNS1 (Rongetal., 2011).Mutations in thegenes
encoding the subunits of the AP-4 complex, as well as those en-
coding spatacsin and spastizin account for severe neurodegener-
ative disorders, hereditary spastic paraplegias (Tesson et al.,
2015). In addition, loss of function of spinster, the Drosophila ho-
molog of SPNS1, leads to neurodegeneration (Nakano et al.,
2001). Thesedata highlight the importanceof the lysosome recov-
ery pathway for neuron survival. The accumulation of autolyso-
somes inneuronsofa knockoutmouse lackingspatacsinwaspro-
posed as evidence that defective autophagic lysosome recovery
can contribute to neurodegeneration (Varga et al., 2015). How-
ever, the mechanism of ALR has so far only been investigated in
cultured non-neuronal cells.
Several of the proteins involved in the recycling of lysosome
membranes are directly implicated in membrane curvature,
such as clathrin and AP-2 and AP-4 complexes (Rong et al.,Reports 23, 3813–3826, June 26, 2018 ª 2018 The Author(s). 3813
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2012). Recently, we implicated the loss of spatacsin, a protein
required for the initiation of ALR (Chang et al., 2014), in lysosomal
accumulation of lipids in a knockout mouse model (Branchu
et al., 2017), therefore linking lysosome membrane recycling to
lipid metabolism. Spatacsin is encoded by the SPG11 gene (Ste-
vanin et al., 2007). Mutations in this gene lead to a spastic gait
disorder variably associated with cognitive impairment, periph-
eral neuropathy, cerebellar ataxia, parkinsonism, and retinal
degeneration (Hehr et al., 2007; Stevanin et al., 2007). Knocking
out Spg11 in mice is responsible for early cognitive and motor
deficits, consistent with the symptoms observed in the majority
of patients with mutations in the SPG11 gene (Branchu et al.,
2017). The accumulation of lipids that was observed in the brain
of Spg11 knockout micewas also detected in post-mortem brain
samples of a SPG11 patient (Branchu et al., 2017). However, the
mechanisms underlying lipid accumulation and neurodegenera-
tion are unknown.
Here, we show that loss of spatacsin leads to the accumula-
tion of simple gangliosides in lysosomes. The accumulation of
gangliosides is a consequence of impaired recycling of lyso-
somes caused by the absence of functional spatacsin.
Decreasing ganglioside levels prevented the accumulation of
autophagy markers in lysosomes in cultured neurons, improved
neuron survival in vitro, and prevented motor phenotype caused
by inactivation of zspg11 in a zebrafish SPG11 model. Our work
therefore highlights the importance of lysosome membrane re-
cycling to prevent the detrimental role of gangliosides in neuronal
death.
RESULTS
Loss of Spatacsin Promotes the Progressive
Accumulation of Gangliosides in Lysosomes in Neurons
Loss of spatacsin in mice leads to lysosomal accumulation of
lipids in neurons (Branchu et al., 2017). We investigated the
nature of the lipids that accumulate in the cerebral cortex of
8-month-old Spg11/ mice by performing a lipidomic analysis.
The levels of free fatty acids, ceramides, and lysophospholipids
were significantly lower in the cortex of Spg11/mice than con-
trol mice. Only GM2 ganglioside levels were significantly higher
in the cortex of Spg11/ mice than in control mice (Table S1).
Immunostaining with a specific antibody showed that GM2 colo-
calized with lysosomes in Spg11/ mice, from the age of
6 weeks, whereas it was seen as rare small punctae in neurons
of control mice (Figure 1A). The proportion of neurons with
GM2 staining in lysosomes was higher in Spg11/ than in
Spg11+/+mice at the age of 6 weeks, and by the age of 8months,
most neurons in motor cortex of Spg11/ mice showed GM2
accumulation (Figure 1B). Quantification of the fluorescence in-
tensity showed that GM2 levels were higher in Spg11/ than
Spg11+/+ cortical neurons at all ages (Figure 1C). GM2 accumu-
lated in large lysosomes in knockoutmice as indicated by the co-
localization of GM2 and Lamp1 staining (Figure 1A). These data
showed that the loss of spatacsin function leads to early and pro-
gressive accumulation of the GM2 ganglioside in the lysosomes
of neurons in the cerebral cortex. Activity of hexosaminidase A,
an enzyme involved in lysosomal catabolism of GM2, was not
decreased in cortex extracts obtained from Spg11/ mice3814 Cell Reports 23, 3813–3826, June 26, 2018compared to controls, suggesting that accumulation of GM2
was not due to an impaired activity of this enzyme (Figure S1A).
Our lipidomic analysis was performed on the whole cortex. It is
thus possible that other lipids may accumulate in lysosomes
despite the absence of a global change in their levels. Therefore,
we purified fractions enriched in lysosomes from the brains of
Spg11+/+ and Spg11/ mice (Figures S1B and S1C), and ex-
tracted lipids using the Folch procedure (Folch et al., 1957). Lip-
idomic analysis was performed on the Folch upper phase, which
contains gangliosides. The levels of gangliosides GM2, GM3,
GD2, and GD3 were markedly higher in lysosomal fractions ob-
tained from Spg11/mouse brains than those of control brains
(Table 1). We confirmed the enrichment of these gangliosides in
lysosomes by immunostaining with specific antibodies (Figures
S2A–S2C). Quantification of fluorescence intensity showed
that the levels of the four lipid species increased with age
and were higher in Spg11/ mouse brains than control brains
(Figures 1C–1F). The gangliosides GM3, GD2, and GD3 were
colocalized with lysosomes, as GM2 was, consistent with their
accumulation in lysosomes. The levels of complex gangliosides
(GM1, GD1, and GT1) were slightly, but not significantly higher in
the lysosome-enriched fractions (Table 1). Accordingly, there
was no difference in the localization of GM1 between Spg11+/+
and Spg11/ mouse brain as assessed by immunostaining
(Figures S2D and S2E).
Loss of Spatacsin Promotes the Early Accumulation of
Gangliosides in Lysosomes in Human Neurons
We tested whether the accumulation of gangliosides is also rele-
vant for human pathology using induced pluripotent stem cells
(iPSCs) derived from fibroblasts of two independent SPG11 pa-
tients and two sex- and age-matched controls. iPSCs of SPG11
patients and healthy subjects that were validated withmarkers of
pluripotency (Figure S3A) were differentiated into brain organo-
ids with predominant cortical identity using a free-floating tridi-
mensional culture method (Pasxca et al., 2015). After 90 days of
differentiation, the organoids were organized in layers of radial
glial cells labeled by Pax6 and Nestin, and peripheral layers of
neurons that expressed bIII-tubulin and NeuN (Figure 2A; data
not shown). We examined by immunostaining whether ganglio-
sides accumulated in lysosomes in the peripheral layer of neu-
rons (Figures 2B–2F). GM2, GM3, and GD3 showed a punctate
immunostaining pattern in the neurons of the peripheral layer
of control and SPG11 brain organoids, and the staining largely
colocalized with lysosomes in the neurons of the SPG11
brain organoids (Figures 2B and S3B–S3D). Quantification of
fluorescence intensity showed GM2 and GM3 levels to be
higher in SPG11 cortical organoids than control organoids
(Figures 2C–2F). Furthermore, the variance of the fluorescence
intensity of GM2, GM3, and GD3 staining was also higher in or-
ganoids derived from SPG11 patients than those derived from
healthy controls, consistent with their accumulation in lyso-
somes. There was no difference in GD2 staining between orga-
noids derived from SPG11 patients and healthy controls, in
agreement with the lack of a difference in GD2 staining in the
cortices of Spg11+/+ and Spg11/ mice at early stages (Fig-
ure 1E). Overall, these data show that simple gangliosides accu-
mulated in lysosomes of the human neurons, starting at early
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Figure 1. Spatacsin Loss Promotes Lysosomal Accumulation of Gangliosides in Neurons of the Cortex
(A and B) GM2 (green) and Lamp1 (magenta) immunostaining ofSpg11+/+ andSpg11/ neurons of the layer V of themotor cortex from 6-week-old and 8-month-
old mice observed by confocal microscopy with a 603 (A) or 203 (B) objective. Images showing the accumulation of GM2-positive staining in lysosomes
surrounded by Lamp1 staining in 6-week-old and 8-month-old Spg11/ animals. Insets show the view along the z axis (A). Scale bars: 10 mm (A) and 50 mm (B).
(C–F) Quantification of the mean of the GM2 (C), GM3 (D), GD2 (E), and GD3 (F) immunostaining intensity per neuron. Quantification was performed in neurons of
the layer V of motor cortex that were detected by their large soma. The graphs show the mean ± SEM values. N = 10–15 neurons quantified per cortex slices in
five cortex slices of five independent mice. Differences between Spg11+/+ and Spg11/ were analyzed by a Kruskal-Wallis test at each time point; * p% 0.05,
***p% 0.0001.
See also Table S1 and Figures S1 and S2.stages of development represented by the cortical organoid
model (Pasxca et al., 2015). This prompted us to investigate
how spatacsin regulates the levels of gangliosides in lysosomes.
Spatacsin Is Recruited to Lysosomes Containing
Gangliosides in Primary Cultures of Cortical Neurons
We analyzed whether gangliosides accumulated in lysosomes of
primary cultures of cortical neurons derived from Spg11/
mouse embryos. By immunostaining, GM2, GM3, GD2, and
GD3 significantly accumulated in lysosomes in cultured neurons
derived from Spg11/ embryos (Figures 3A–3E and S4A–S4C).
Primary cultures of cortical neurons are thus a good model to
investigate themechanisms leading to ganglioside accumulationin lysosomes. GM2 was the ganglioside that accumulated the
most in lysosomes, and lipidomic analysis showed higher levels
of GM2 in Spg11/ than in Spg11+/+ neurons (Figure S4D). We
therefore used it as a marker for ganglioside accumulation in
subsequent experiments.
We investigated the role of spatacsin in ganglioside meta-
bolism by transfecting neurons with a V5-tagged spatacsin. In
control conditions, the protein had a diffuse localization
throughout the cytoplasm. However, it was partially colocalized
with the few GM2-positive lysosomes in these cells (Figure 3F).
To investigate the link between gangliosides and spatacsin, we
enforced accumulation of gangliosides in lysosomes by downre-
gulating the expression of neuraminidase 1 (Neu1), an enzymeCell Reports 23, 3813–3826, June 26, 2018 3815
Table 1. Relative Amounts of Various Classes of Gangliosides in Lysosome-Enriched Fractions Obtained from the Brains of 8-Month-
Old Spg11+/+ and Spg11/ Mice
Spg11+/+ Spg11/ Fold Change
GM3 N = 8 N = 7 –
GM3 (d18:1/18:1) 14.2 ± 3.1 42.3 ± 5.3a 2.98
GM3 (d18:1/18:0) 518.2 ± 89.5 1,316.6 ± 194.1a 2.54
GM3 (d18:1/20:0) 51.1 ± 8.7 170.3 ± 24.5a 3.34
GM2
GM2 (d18:1/18:0) 286.5 ± 46.3 957.6 ± 119.5a 3.34
GM2 (d18:1/20:0) 68.9 ± 12.3 296.9 ± 40.9a 4.31
GD3
GD3 (d18:1/18:0) 155.8 ± 23.9 321.0 ± 45.2a 2.06
GD3 (d18:1/18:0) 139.8 ± 26.7 307.7 ± 41.0a 2.20
GD3 (d18:1/20:0) 39.9 ± 8.5 87.1 ± 12.3a 2.18
GD2
GD2 (d18:1/18:0) 53.1 ± 8.4 145.3 ± 22.7a 2.73
GD2 (d18:1/20:0) 54.7 ± 10.9 159.9 ± 24.2a 2.93
GM1
GM1 (d18:1/18:1) 52.8 ± 11.7 84.9 ± 10.7 1.61
GM1 (d18:1/18:0) 478.8 ± 87.2 778.7 ± 91.5 1.63
GM1 (d18:1/20:0) 198.6 ± 40.5 322.3 ± 42.7 1.62
GD1
GD1 (d18:1/18:1) 280.2 ± 65.6 338.4 ± 40.1 1.21
GD1 (d18:1/18:0) 4,025.6 ± 1221.1 4,648.3 ± 615.8 1.15
OAc-GD1 (d18:1/18:0) 174.3 ± 39.3 222.2 ± 19.0 1.27
GD1 (d18:1/20:0) 1,653.3 ± 404.0 1,781.7 ± 225.9 1.08
GT1
GT1 (d18:1/18:0) 493.4 ± 174.0 535.5 ± 74.3 1.09
OAc-GT1 (d18:1/18:0) 192.9 ± 60.9 243.4 ± 34.1 1.26
GT1 (d18:1/20:0) 220.6 ± 74.7 230.1 ± 32.5 1.04
OAc-GT1 (d18:1/20:0) 140.8 ± 37.8 163.7 ± 23.7 1.16
Arbitrary units, normalized to lysosomal protein concentration.
ap < 0.05, t test with Benjamini-Hochberg procedure to correct for multiple testing.involved in the lysosomal degradation of gangliosides (Bonten
et al., 1996). We used two independent microRNA (miRNA)
sequences that efficiently downregulated Neu1 expression
(Figure S4E). Downregulation of Neu1 promoted significant
accumulation of GM2 in lysosomes in transfected Spg11+/+
and Spg11/ neurons (Figures S4F and S4G), suggesting that
neuraminidase activity and lysosome membrane recycling are
independent pathways to clear gangliosides. In wild-type neu-
rons that were transfected with both a miRNA targeting Neu1
and expressing V5-tagged spatacsin, the latter was strongly en-
riched in GM2-positive lysosomes (Figure 3F), suggesting that
spatacsin is recruited to lysosomes containing gangliosides.
Lysosome Membrane Recycling Promotes Ganglioside
Clearance from Lysosomes
Loss of spatacsin in fibroblasts is responsible for the presence of
large lysosomes (Renvoise´ et al., 2014). This phenotype is the
consequence of impaired lysosome recycling analyzed in cell3816 Cell Reports 23, 3813–3826, June 26, 2018lines by monitoring the formation of tubules emanating from
Lamp1-positive vesicles by live imaging (Chang et al., 2014). In
cultured neurons, we did not detect tubules emanating from ly-
sosomes by live imaging (Figure S5A), even with treatment
such as dynasore, a dynamin inhibitor that enhances the number
of lysosomal tubules in fibroblasts (Chang et al., 2014). However,
we observed that the average number of lysosomes immuno-
stained with Lamp1 and with an apparent diameter larger than
1 mm was higher in Spg11/ neurons than in control neurons
(Figure 3G). We evaluated the role of gangliosides in the forma-
tion of large lysosomes using miglustat, which inhibits glucosyl-
ceramide synthase, an early step in glycosphingolipid synthesis,
and is known to decrease GM2 levels in a model of Sandhoff dis-
ease (Jeyakumar et al., 1999). In primary cultures of cortical neu-
rons, miglustat significantly decreased the levels of GM2 in a
dose-dependent manner (Figures S5B and S5C), but it did not
change the number of large lysosomes (Figure 3G). To confirm
these data, we used two independent miRNAs that target GM3
AB
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Figure 2. Spatacsin Loss Promotes Lysosomal Accumulation of Gangliosides in Neurons Derived from SPG11 Patients
(A) Immunostaining of brain organoids differentiated for 90 days in vitro with antibodies against the progenitor marker Pax6 and the neuron-specific marker bIII-
tubulin. Note that neuronal cells are concentrated at the periphery of the organoids. Scale bar: 50 mm.
(B) GM2 (green) and Lamp1 (magenta) immunostaining in the neuronal layer of organoids derived from healthy subjects or SPG11 patients. bIII-Tubulin (yellow)
shows the neuronal identity of the cells that were analyzed. Confocal microscopy images showing the accumulation of GM2-positive staining in lysosomes
labeled by Lamp1 staining of organoids derived from SPG11 patients (arrowheads). Scale bar: 10 mm.
(C–F) Quantification of the mean of the GM2 (C), GM3 (D), GD2 (E), and GD3 (F) immunostaining intensity per neuron. The graph shows mean ± SEM values.
N = 10–15 neurons quantified per slices in five slices obtained from three independent organoids. One-way ANOVA; ***p% 0.001.
See also Figure S3.synthase, the enzyme producing the first ganglioside in the
biosynthetic pathway, and from which all other sialylated gangli-
osides are generated (Xu et al., 2010). Expression of these
miRNAs significantly decreased the expression of GM3 synthase
mRNA and GM2 levels (Figures S5D–S5F). The number of large
lysosomes was unchanged when GM3 synthase was downregu-lated in Spg11+/+ and Spg11/ neurons (Figure S5G). This indi-
cates that accumulation of large lysosomes does not depend on
de novo synthesis of gangliosides. We thus hypothesized that
the accumulation of GM2 in lysosomes occurs as a conse-
quence of inhibition of lysosome membrane recycling in
Spg11/ cells.Cell Reports 23, 3813–3826, June 26, 2018 3817
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Figure 3. Spatacsin Loss Induces Lysosomal Accumulation of Gangliosides in Primary Cultures of Mouse Cortical Neurons
(A) GM2 (green) and Lamp1 (magenta) immunostaining of Spg11+/+ and Spg11/ neurons cultured for 6 days in vitro. Confocal microscopy images showing the
accumulation of GM2-positive staining of lysosomes labeled by Lamp1 staining. Scale bar: 10 mm.
(B–E) Quantification of the proportion of GM2 (B), GM3 (C), GD2 (D), and GD3 (E) staining that is localized in lysosomes. The graphs show themean ± SEM values.
N = 58–71 neurons quantified in three independent neuron preparations. t test; **p% 0.01 and ***p% 0.001.
(F) Immunostaining of GM2 ganglioside (green), Lamp1 (cyan), and Spatacsin-V5 (magenta) in wild-type neurons co-transfected with vectors allowing expression
of Spatacsin-V5 and either control miRNA or miRNA downregulating Neu1. Spatacsin is enriched around GM2-positive vesicles (arrowheads). Scale bar: 10 mm.
(G) Quantification of the number of lysosomes detected with Lamp1 immunostaining and with a diameter larger than 1 mm in Spg11+/+ and Spg11/ neurons
cultured for 6 days in vitro and treated or not with miglustat (100 mM). The graphs show themean ± SEM values. N = 62–64 neurons quantified in four independent
neuron preparations (control); N = 24–34 neurons quantified in three independent neuron preparations (miglustat). One-way ANOVA, followed by Holm-Sidak
post hoc test; ***p% 0.001.
See also Figure S4.To test this hypothesis, we analyzed the role of clathrin, one
of the proteins required for recycling of lysosome membrane
(Rong et al., 2012). Downregulation of clathrin levels using
two independent miRNAs (Figures S5H and S5I) led to higher
number of large lysosomes per neurons (Figure 4A). Inhibition
of lysosome membrane recycling following clathrin downregu-
lation was associated with a higher amount of GM2 ganglio-
side in lysosomes (Figure 4B), suggesting that inhibition of
lysosome membrane recycling prevented or slowed down
clearance of gangliosides. In Spg11/ neurons, clathrin colo-
calized with lysosomes containing high amounts of the GM2
ganglioside (Figure 4C). The proportion of cellular clathrin co-3818 Cell Reports 23, 3813–3826, June 26, 2018localized with the GM2 was higher in Spg11/ neurons than
control neurons (Figure 4D). Accordingly, clathrin staining
was high for large autofluorescent lysosomes that contain
high amounts of GM2 (Figure 1A) in the brains of Spg11/
mice (Figure 4E). This suggests that clearance of gangliosides
was blocked downstream of clathrin recruitment in the
absence of spatacsin.
In a two-hybrid screen, we found that dynamin-1, a homolog of
dynamin-2 that is important for termination of the lysosome recy-
cling (Schulze et al., 2013), is a putative interactor of the C-termi-
nal domain of spatacsin. We validated this interaction by co-
immunoprecipitation in HeLa cells (Figure 4F). We analyzed
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Figure 4. Spatacsin Promotes Clearance of Gangliosides from Lysosomes
(A) Quantification of the number of lysosomes with a diameter larger than 1 mm in Spg11+/+ and Spg11/ neurons expressing control miRNA or miRNA
downregulating clathrin heavy chain (CHC). The graphs show the mean ± SEM values. N = 35–50 neurons quantified in two independent neuron preparations.
One-way ANOVA, followed by Holm-Sidak post hoc test; *p = 0.03 and ***p% 0.001.
(B) Quantification of the proportion of GM2 staining that is localized in lysosomes. The graphs show the mean ± SEM values. N = 36–49 neurons quantified in two
independent neuron preparations. One-way ANOVA, followed by Holm-Sidak post hoc test; **p = 0.0017.
(legend continued on next page)
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whether the absence of spatacsin had an impact on dynamin
recruitment to lysosomes. Western blot performed on the lyso-
some-enriched fractions that were used for lipidomic analysis
(Table 1) showed that dynamin was markedly less abundant in
lysosome fractions obtained from Spg11/ than Spg11+/+
mouse brains (Figure 4G), while no difference was observed in
whole-brain extracts. Immunostaining on cultured neurons
showed a decreased amount of dynamin colocalized with
Lamp1-positive lysosomes in Spg11/ than Spg11+/+ neurons
(Figure S5J). These results, together with the enrichment of spa-
tacsin on lysosomes containing GM2 (Figure 3F), led us to hy-
pothesize that spatacsin participates in recruitment of dynamin
to lysosomes to clear gangliosides. To test this hypothesis, we
inhibited dynamins using dynasore treatment, which promoted
higher levels of GM2 in lysosomes (Figure 4H). Furthermore, dy-
nasore treatment in control neurons increased the number of
large lysosomes (Figure 4I), consistent with the role of dynamin
in late step of lysosome membrane recycling. Dynasore also
led to the enrichment of V5-spatacsin in lysosomes containing
GM2 (Figure 4J), suggesting that spatacsin is implicated
upstream of dynamin. Altogether, these data suggest that the
machinery implicated in lysosome membrane recycling in
fibroblasts is used by neurons to clear gangliosides from
lysosomes.
High Levels of Gangliosides in Lysosomes Contribute to
the Accumulation of Autophagy Markers in Lysosomes
We then investigated the consequences of ganglioside accumu-
lation on lysosome function. Catalytic activity monitored by the
Magic red cathepsin B substrate was not altered in Spg11/
neurons (Figure S6A), suggesting that it was not altered by accu-
mulation of gangliosides. Loss of spatacsin was shown to result
in accumulation of autolysosomes (Chang et al., 2014; Varga
et al., 2015). Accordingly, even if the global levels of the auto-
phagy marker p62 were similar in total brain extracts of
8-month-old Spg11/ and Spg11+/+mice, p62 was more abun-
dant in lysosome-enriched fractions obtained from Spg11/
thanSpg11+/+mouse brains (Figure 4G). Similarly, in primary cul-
tures of neurons, the proportion of lysosomes that were positive
for the autophagic marker p62, was higher in Spg11/ neurons(C) Immunostaining of Spg11/ neurons with Lamp1 (cyan), GM2 (yellow), and
GM2 marker that also show recruitment of clathrin. Scale bar: 5 mm.
(D) Quantification of the proportion of clathrin colocalized with GM2-positive ve
(Spg11/) neurons quantified in three independent neuron preparations. t test;
(E) Confocal microscopy images of autofluorescence (green), Lamp1 (magenta),
neurons from 8-month-old animals showing the accumulation of clathrin surroun
(F) Western blot showing the interaction of GFP-spatacsin (domain 1943–2443
Western blot signals were detected by chemiluminescence.
(G) Left: western blots showing the relative amount of Lamp1, p62, clathrin hea
fractions obtained fromSpg11+/+ and Spg11/mouse brains.Western blot signa
of the band intensities. The graphs show the mean ± SEM. Preparations from N
(H) Quantification of the proportion of GM2 staining that is localized in lysosome
values. N = 73–124 neurons quantified in three independent neuron preparatio
**p = 0.01.
(I) Quantification of the number of lysosomes with a diameter larger than 1 mm in ne
N = 49–54 neurons quantified in two independent neuron preparations. One-way
(J) Immunostaining of GM2 ganglioside (yellow) and Spatacsin-V5 (magenta) in ne
with either vehicle or dynasore (40 mM) for 2 hr. Spatacsin is enriched around GM
See also Figure S5.
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in cultured Spg11/ neurons (Figure 5A). We then investigated
whether GM2 contributed to increase the proportion of lyso-
somes containing p62 marker. Close examination of GM2 stain-
ing in neurons showed that it mainly accumulated in a subset of
lysosomes that were also stained with p62 (Figure 5B). The pro-
portion of lysosomes stained with p62 and GM2 antibodies was
higher in Spg11/ neurons than in control neurons and
increased over time (Figure 5C), suggesting that GM2 accumula-
tion might contribute to the increase in lysosomes displaying
autophagy markers.
To test this hypothesis, we decreased the amount of ganglio-
sides in lysosomes using miglustat (100 mM), or by downregulat-
ing GM3 synthase (Figures S5D–S5F). This strongly decreased
the proportion of lysosomes positive for the p62 marker in
Spg11/ neurons (Figures 5D and 5E). Overall, our data suggest
that the accumulation of GM2 in lysosomes prevents the degra-
dation of their content. Conversely, we enforced accumulation of
GM2 in lysosomes by downregulation of the expression of Neu1.
This resulted in a significant increase in the proportion of lyso-
somes positive for the autophagic marker p62 (Figure 5F).
Together, these data suggest that ganglioside accumulation
leads to the accumulation of the autophagy marker p62 in
lysosomes.
Gangliosides Contribute to Neurodegeneration in
Cultured Neurons
We then investigated whether accumulation of gangliosides
contribute to neurodegeneration using primary cultures of
mouse cortical neurons. Basal neuronal death was similar in
Spg11+/+ and Spg11/ neurons (Figures 6A and 6B). We thus
evaluated neuronal death triggered by glutamate, which occurs
in many models of neurodegenerative diseases (Lewerenz and
Maher, 2015) and was shown to increase ganglioside levels in
cultured neurons (Park et al., 2016). Accordingly, we observed
a moderate, but statistically significant, increase in overall GM2
immunoreactivity, both in control and Spg11/ neurons
(Figure S6B).
Neuronal death triggered by glutamate was significantly
higher in neurons obtained from Spg11/ embryos thanclathrin (magenta) antibodies. Arrowheads point to lysosomes positive for the
sicles. The graphs show the mean ± SEM values. N = 88 (Spg11+/+) and 102
**p = 0.0023.
and clathrin (cyan) immunostaining of Spg11+/+ and Spg11/ cortical motor
ding autofluorescent lysosomes. Scale bars: 10 mm.
) with dynamin in HeLa cells expressing GFP or GFP-spatacsin 1943–2443.
vy chain (CHC), and dynamin in whole-brain lysates and lysosome-enriched
ls were detected using an infrared imaging system. Right: relative quantification
= 3 independent animals. One-tailed Mann-Whitney U test; *p = 0.05.
s in neurons treated with 40 mM dynasore. The graphs show the mean ± SEM
ns. One-way ANOVA, followed by Holm-Sidak post hoc test; *p = 0.02 and
urons treated with 40 mMdynasore. The graphs show the mean ± SEM values.
ANOVA, followed by Holm-Sidak post hoc test; **p = 0.001 and ***p% 0.001.
urons transfected with vector allowing expression of Spatacsin-V5 and treated
2-positive vesicles (arrowheads). Scale bar: 10 mm.
A B C
D E F
Figure 5. GM2 Accumulation in Lysosomes Promotes the Accumulation of Autophagy Marker p62 in Lysosomes
(A) Proportion of lysosomes stained with Lamp1 that were also positive for p62 in Spg11+/+ and Spg11/ neurons after 3 and 6 days in vitro. The graph shows the
mean ± SEM values. Two-way ANOVA, followed by Holm-Sidak post hoc test; *p = 0.04 and ***p < 0.001.
(B) Immunostaining of Spg11/ neurons with GM2 antibody (cyan), lysosomal marker Lamp1 (magenta), and the autophagy marker p62 (yellow). Arrowheads
indicate lysosomes, which were positive for p62 and GM2 staining. Scale bar: 10 mm.
(C) Proportion of lysosomes stained with Lamp1 that were also positive for both p62 and GM2 in Spg11+/+ and Spg11/ neurons after 3 and 6 days in vitro. The
graph shows the mean ± SEM values. Two-way ANOVA, followed by Holm-Sidak post hoc test; ***p < 0.001.
(D) Effect of miglustat treatment (100 mM) on the proportion of lysosomes stained with Lamp1 that were also positive for p62 in Spg11+/+ and Spg11/ neurons
after 6 days in vitro. The graph shows the mean ± SEM values. Two-way ANOVA, followed by Holm-Sidak post hoc test; ***p < 0.001.
(E) Effect of the downregulation of GM3 synthase with two independent miRNAs (GM3S-1 and GM3S-2) on the proportion of lysosomes stained with Lamp1 that
were also positive for p62 in control neurons after 6 days in vitro. The graph shows the mean ± SEM values. Two-way ANOVA, followed by Holm-Sidak post hoc
test; ***p < 0.001.
(F) Effect of Neu1 downregulation with two independent miRNAs (Neu1-1 and Neu1-2) on the proportion of lysosomes stained with Lamp1 that were also positive
for p62 in control neurons after 6 days in vitro. The graph shows the mean ± SEM values. One-way ANOVA, followed by Holm-Sidak post hoc test; ***p < 0.001.
In (A–D), day in vitro 3 (DIV3), N = 47–50 neurons quantified in two independent neuron preparations; DIV6, N = 173–193 neurons quantified in four independent
neuron preparations. In (E), N = 7–29 neurons quantified in two independent neuron preparations. In (F), N = 57–68 neurons quantified in three independent neuron
preparations.control neurons (Figures 6A and 6B). Miglustat treatment of
Spg11/ neurons decreased glutamate-induced neuronal
death in a dose-dependent manner (Figure 6A). Similar data
were obtained when GM2 levels were decreased after downre-
gulation of GM3 synthase (Figure 6B). These data suggest
that GM2 accumulation contributes to neuronal death. We
confirmed this hypothesis by inducing the accumulation of gan-
gliosides in lysosomes, after downregulating Neu1, and moni-
toring neuronal death triggered by glutamate. Increasing
ganglioside levels sensitized the neurons to glutamate-trig-
gered cell death (Figure 6C).
We monitored p62 levels in control and Spg11/ neurons
treated with glutamate to determine whether ganglioside-medi-
ated accumulation of autophagy markers in lysosomes contrib-
uted to glutamate-induced neuronal death. We observed no dif-
ference in p62 levels in untreated neurons. In contrast, glutamate
treatment significantly increased p62 levels in Spg11/ neu-
rons, which was inhibited when ganglioside levels were
decreased by miglustat treatment (Figure S6C). These data sug-
gest that gangliosides contribute to neuronal death by promoting
the accumulation of the autophagy marker p62.Inhibition of Ganglioside Synthesis in ZebrafishRescues
the Motor Dysfunction Induced by Loss of Spatacsin
Finally, we tested the pathological role of ganglioside accumula-
tion in an in vivo model. Since gangliosides accumulate in lyso-
somes at embryonic stages, we inhibited spatacsin expression
in zebrafish larvae using injection of antisense morpholinos,
which leads to a motor phenotype (Martin et al., 2012). Zebrafish
larvae injected with zspg11 antisense morpholinos had a stron-
ger GM2 staining in the telencephalon than larvae injected with
mismatch morpholinos, as assessed by immunostaining. The
stronger staining with GM2 antibody was corrected in larvae
treated by miglustat (Figures 6D and 6E). We therefore were
able to monitor the role of gangliosides in the motor phenotype
in this model. Larvae injected with zspg11 antisense morpholi-
nos presented with a motor phenotype that was characterized
by either a loss ofmotility or a paralysis (Figure 6F) that was rarely
or never observed in larvae injected with a mismatch morpholino
or in uninjected larvae, respectively. When larvae were treated
with miglustat, the proportion of paralyzed larvae was signifi-
cantly reduced in a dose-dependent manner compared to con-
trols (Figure 6F). To confirm these data, we monitored theCell Reports 23, 3813–3826, June 26, 2018 3821
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Figure 6. Decreasing Ganglioside Synthesis Prevents Neuronal Death and Improves Motor Dysfunction in Zebrafish Deficient for Spatacsin
and Modeling SPG11
(A) Quantification of neuronal death 30 hr after incubation of neurons with glutamate (200 mM) in primary cultures of Spg11+/+ orSpg11/ cortical neurons treated
withmiglustat. The graph shows themean ±SEM values. N = 5–14 independent experiments. One-way ANOVA, followed by Holm-Sidak post hoc test; *p = 0.002
and ***p < 0.001.
(B) Quantification of neuronal death 30 hr after incubation of neurons with glutamate (200 mM) in primary cultures of Spg11+/+ and Spg11/ cortical neurons
transfected with vectors expressing control miRNA or two different miRNAs against GM3 synthase. The graph shows the mean ± SEM. N = 3–8 independent
experiments. One-way ANOVA, followed by Holm-Sidak post hoc test; *p < 0.02 and ***p < 0.001.
(legend continued on next page)
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distance traveled by larvae following a touch-evoked escape
response. Morphants injected with zspg11 antisense morpholi-
nos showed significantly shorter touch-induced escapes than
larvae injected with control morpholinos (Videos S1 and S2).
This phenotype was significantly corrected when larvae were
treated with miglustat (Figures 6G and 6H; Video S3), while mi-
glustat had no effect on morphants injected with mismatch mor-
pholino. Together, these data demonstrate the deleterious role
of gangliosides in an in vivo model of the SPG11 pathology.
DISCUSSION
Using models of hereditary spastic paraplegia caused by muta-
tions in the SPG11 gene, as well as inhibition of proteins impli-
cated in ALR, we show that impairment of lysosome membrane
recycling in neurons leads to accumulation of gangliosides in ly-
sosomes, thereby contributing to neurodegeneration.
The recycling of lysosomal membranes has beenmainly inves-
tigated in cultured cell lines or fibroblasts, and few data are avail-
able in neuronal models. Loss of spatacsin leads to accumula-
tion of autolysosomes and depletion of lysosomes in the brain
of an Spg11 knockout mouse model (Varga et al., 2015), but
the molecular mechanisms underlying this phenomenon have
not been entirely elucidated. ALR described in cell lines occurs
after the induction of autophagy and leads to the formation of tu-
bules extruding from autolysosomes (Chang et al., 2014; Yu
et al., 2010). In neurons, we were unable to promote autophagy
following starvation, as previously observed (Mizushima et al.,
2004), and did not observe tubules extruding from lysosomes.
In nutrient-rich conditions, lysosome recycling mainly occurs
via vesiculation, a mechanism implicating notably the phosphoi-
nositide kinase PI4KB and clathrin (Sridhar et al., 2013). Spatac-
sin interacts with PI4KB and was proposed to participate in lyso-
some vesiculation in nutrient-rich conditions (Chang et al., 2014).
The presence of large lysosomes observed in neurons when
spatacsin is absent or when clathrin or dynamin are inhibited
could thus be a consequence of impaired recycling of lysosomal
membrane mediated by vesiculation.
The loss of spatacsin leads to a strong accumulation of gangli-
osides in lysosomes in the cerebral cortex of mice, which
increased with age, but was not due to impairment of hexosa-
minidase A activity. Gangliosides are normally degraded into
ceramide and sialic acid in lysosomes, and these metabolites
are transported to the endoplasmic reticulum (Tettamanti et al.,(C) Quantification of neuronal death 30 hr after incubation of neurons with glutam
transfected with vectors that downregulate Neu1 with two independent miRNAs
pendent experiments. One-way ANOVA, followed by Holm-Sidak post hoc test;
(D and E) Immunostaining (D) and quantification (E) of GM2 immunostaining in the
pmol mismatch (mm)morpholino (MO). Injection of zspg11spl morpholino increase
corrected when morphants were treated with miglustat. N = 6–12 morphants an
(F) Phenotype of morphants that were non-injected or injected with 1.2-pmol zs
phants were classified as normal phenotype, slowly swimming, paralyzed, or c
paralyzed or slowly swimming phenotypes. Treatment withmiglustat decreased th
groups. Chi square test; ***p < 0.0001.
(G and H) Tracking (G) and quantification of distance traveled (H) by larvae followin
the swimming of morphants, which was corrected when treated by miglustat. The
One-way ANOVA; ***p < 0.001.
See also Figure S6.2003). Our lipidomic data showed that the accumulation of gan-
gliosides is paralleled by a decrease in ceramide, which could be
a consequence of impaired ganglioside clearance from lyso-
somes. The implication of spatacsin in initiation of lysosome
membrane recycling (Chang et al., 2014) led us to hypothesize
that recycling of lysosome membrane could contribute to clear
gangliosides from lysosomes. This is supported by the accumu-
lation of gangliosides observed when lysosomemembrane recy-
cling is inhibited by downregulation of clathrin or inhibition of dy-
namin. The coimmunoprecipitation of spatacsin with dynamin,
and the decreased amount of dynamin in lysosomes in the
absence of spatacsin, suggests that spatacsin recruits dynamin
to this subcellular compartment. Thus, spatacsin, besides its
role in initiation of lysosome membrane recycling (Chang et al.,
2014), could contribute to the late stage of recycling by recruiting
dynamin to promote fission and release membrane from lyso-
somes. Impaired vesicle fission and accumulation of clathrin-
coated buds have been observed in cortical granules of oocytes
in the souffle zebrafish mutant that has no spastizin (Kanagaraj
et al., 2014). Spastizin is a spatacsin interactor implicated in lyso-
some membrane recycling (Chang et al., 2014). Its expression is
strongly decreased in the brain of Spg11/mice (Branchu et al.,
2017), which could also contribute to impaired lysosomal mem-
brane recycling. Our data therefore suggest that, in the absence
of spatacsin, impaired lysosome membrane recycling leads to
the progressive accumulation of gangliosides in lysosomes as
the disease progresses.
Inhibition of ganglioside synthesis prevented neuronal death
in vitro but did not compensate for the formation of large lyso-
somes, suggesting that inhibition of lysosome membrane recy-
cling itself is not responsible for neurodegeneration. In contrast,
modulation of ganglioside synthesis showed that thesemolecules
contribute to the accumulation of the autophagy marker p62 in ly-
sosomes. The catalytic activity of the lysosomal protease
cathepsin B was not altered in Spg11/ neurons, but the accu-
mulation of gangliosides could slightly impair other lysosomal ac-
tivities leading to progressive accumulation of autophagic
markers in lysosomes. In the long term, defect in autophagy clear-
ance could contribute to neurodegeneration (Menzies et al.,
2017). Accordingly, the accumulation of gangliosides in lyso-
somes paralleled the accumulation of p62 in lysosomes observed
by Varga et al. (2015) and the progression of neurodegeneration
that we observed in the Spg11/ mice (Branchu et al., 2017).
In vitro, glutamate treatment was proposed to inhibit theate (200 mM) in primary cultures of Spg11+/+ and Spg11/ cortical neurons
(Neu1-1 and Neu1-2). The graph shows the mean ± SEM values. N = 6 inde-
***p < 0.001.
telencephalon of morphants injected with 1.2-pmol zspg11spl antisense or 1.2-
d themean and variance of GM2 immunostaining intensity. This phenotypewas
alyzed in each condition. One-way ANOVA; ***p < 0.001.
pg11spl or 1.2-pmol mismatch (mm) morpholino. 48 hr post-fertilization, mor-
urly morphants. Injection of zspg11spl morpholino leads a large proportion of
e proportion of paralyzedmorphants. N = 102–366morphants analyzed in each
g a touch-evoked escape response. Injection of zspg11spl morpholino impaired
graph shows the mean ± SEM. N = 12 morphants analyzed in each condition.
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autophagic flux in hippocampal neurons leading to accumulation
of p62 (Kulbe et al., 2014). Accordingly, decreasing ganglioside
synthesis has a protective action against neuronal death induced
by glutamate in Spg11/ neurons, probably by preventing accu-
mulation of the autophagy marker p62. Altogether, our results
suggest that the accumulation of gangliosides and the subse-
quent accumulation of lysosomes containing autophagicmarkers
are contributing to neuronal death in the absence of spatacsin.
Decreasing gangliosides synthesis therefore appears as a
rational therapeutic strategy to prevent the symptoms caused
by the accumulation of these glycosphingolipids in lysosomes.
Consistently, diminution of gangliosides improved motor pheno-
type in an in vivo zebrafish model of SPG11. Such treatment
should be started at very early stages of the disease as we
showed early accumulation of gangliosides in lysosomes, both
in the Spg11 knockout mouse model and human SPG11 iPSC-
derived neurons. However, it was not possible to test this hy-
pothesis in the Spg11/ mouse model due to the controversial
action ofmiglustat on brain glycosphingolipids (Ashe et al., 2011;
Boudewyn et al., 2017).
In conclusion, we show that gangliosides accumulate in lyso-
somes following impairment of lysosome membrane recycling,
and not only upon metabolic impairment as observed in lyso-
somal storage disorders (Walkley and Vanier, 2009). The accumu-
lation of gangliosides was responsible for accumulation of auto-
phagy markers in lysosomes and neurodegeneration. Since
gangliosides are highly present in the brain (Xu et al., 2010), our
work reveals why proteins implicated in lysosome membrane re-
cycling are often associated with neurodegeneration, and pro-
vides a rational therapeutic strategy for neurodegenerative dis-
eases linked to such lysosomal dysfunction. Accumulation of
undigested material in lysosomes with abnormal morphology
was also observed in SPG4, SPG8, SPG15, SPG31, and SPG48
models of hereditary spastic paraplegias (Allison et al., 2017; Hirst
et al., 2015;Renvoise´ et al., 2014). Itmight be informative to inves-
tigate lysosome membrane recycling and ganglioside accumula-
tion in these diseases. In addition, gangliosides accumulate in ly-
sosomes in models of quite prevalent neurodegenerative
diseases, such as Alzheimer’s disease (Yang et al., 2014), and it
would be interesting to test whether the recycling of lysosome
membrane is altered in these conditions as well. This would allow
a better understanding of the physiopathological pathway leading
to neuronal death and indicate whether these patients can benefit
from the same therapeutic approaches.
EXPERIMENTAL PROCEDURES
Ethical Approval
The care and treatment of animals followed European legislation (no. 2010/63/
UE) and national (Ministe`re de l’Agriculture, France) guidelines for the deten-
tion, use, and ethical treatment of laboratory animals. All experiments on ani-
mals were approved by the local ethics committee (approval no. A751319 and
ce5/2012/057) and conducted by authorized personnel. Patient-derivedmate-
rials were obtained through procedures approved by the ethics committee
with the written, informed consent of the family (approval RBM-1-029).
Spg11-Knockout Mouse Immunohistochemistry
Spg11-knockout mice were described previously (Branchu et al., 2017).
Immunohistochemistry was performed as previously described (Branchu
et al., 2017). Images were obtained with an Olympus FV-1000 confocal micro-3824 Cell Reports 23, 3813–3826, June 26, 2018scope with a 603 objective (numerical aperture [NA], 1.35). For quantification,
regions of interest (ROIs) corresponding to the cell body of individual neurons
were surrounded using ImageJ, and the mean of fluorescence intensity of
ganglioside immunostaining in each ROI was quantified using the measure
tool. In each brain slice, we analyzed all neurons that were identified by their
morphology and large cell body in the layer V of the motor cortex.
Human SPG11 Fibroblasts
Skin biopsies were collected from two healthy female subjects and two SPG11
female patients. Patient SPG11-1 (FSP-1123-004) carried two heterozygous
truncating mutations in trans (c.2431 C>T, pGln811X; deletion of exon 29).
This patient had normal intellectual development and experienced gait diffi-
culties by age 14, gradually worsened, and became stick-dependent at age
20. Examination at age 23 showed that she could still walk with sticks. Spas-
ticity and weakness was present in the lower limbs, while tone and strength
were normal in the upper limbs. She had increased reflexes with ankle clonus
and bilateral extensor plantar reflex as well as Hoffman sign in the upper limbs.
Deep sensation was normal. She had postural tremor in the arms, normal eye
gaze, and no cognitive impairment. There was no evident cerebellar sign. Pa-
tient SPG11-2 (FSP-1232-003) carried two heterozygous truncating mutations
in trans (c.1951 C>T, pArg651X; c.5623 C>T, pGln1875X). This woman had
onset of spastic gait at age 17. At age 27, she presented with moderate spastic
gait, needing walking aids since age 26, and more recently a wheelchair. She
had increased reflexes in lower limbs, including bilateral extensor plantar re-
flexes, and Hoffman signs were present in the upper limbs. She had moderate
weakness in the legs and decreased deep sensation at the ankles. Bradykine-
sia was evident, and the finger-nose test was performed with mild tremor.
Cognition was clinically normal, and she exhibited no abnormal eye move-
ments. Cerebral imaging showed a thin corpus callosum.
Zebrafish Modeling
Modeling of SPG11 pathology in zebrafish was performed using morpholino
oligonucleotides as described previously (Martin et al., 2012). After morpholino
injection, embryos were maintained at 28C in E3 medium, containing miglu-
stat or DMSO for control groups. At 24 hr post-fertilization (hpf), they were
manually dechorionated using fine forceps. The embryo morphology was
observed at 48 hr post-fertilization.
Biochemical Analyses
Experimental procedures for lipidomic analysis, lysosome fraction purification,
and enzymatic assays are detailed in Supplemental Experimental Procedures.
Cell Culture
Experimental procedures for cultures of primary neurons and iPSCs, as well as
differentiation of organoids are detailed in Supplemental Experimental
Procedures.
Statistics
Statistics were performed using GraphPad Prism software, using the Kruskal-
Wallis, ANOVA, or t tests, depending on the experiments. Multiple compari-
sons after ANOVA were performed with the Holm-Sidak test using GraphPad
Prism. For lipidomic analysis, themcp packagewas usedwith R, version 3.0.2.
Comparison of the means between phenotypes was performed using a t test
with a Benjamini-Hochberg procedure to correct for multiple testing, with a
false-discovery rate of 5%.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, one table, and three videos and can be found with this article online
at https://doi.org/10.1016/j.celrep.2018.05.098.
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